为肝细胞癌武装 GPC3 CAR T 细胞:多少才足够,下一步是什么?
Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?
英文原题:CircRNAs as central regulators of Immunometabolic crosstalk in hepatocellular carcinoma.
CircRNAs as central regulators of Immunometabolic crosstalk in hepatocellular carcinoma.
肝细胞癌(HCC)以深度代谢重编程和高度免疫抑制的肿瘤微环境为显著特征,这两个标志协同驱动肿瘤进展和治疗耐药。
肝细胞癌(HCC)具有显著的代谢重编程和高度免疫抑制性肿瘤微环境,这两大特征协同驱动肿瘤进展和治疗耐药。代谢重塑和免疫逃逸过去通常作为平行过程研究,但整合调控这两条通路的分子调节因子尚未充分界定。环状RNA(circRNA)是一类共价闭合、稳定性极高且调控方式多样的非编码RNA,近年已成为癌症代谢和免疫信号的重要调节因子。然而,其在HCC代谢与免疫交汇处的协同作用尚未得到系统综合。本综述提出一个全面的机制框架,将circRNA视为HCC免疫代谢串扰的核心调节者。我们总结circRNA如何调节糖酵解、脂质重塑、谷氨酰胺代谢和氧化还原平衡,同时调控免疫检查点通路、巨噬细胞极化、T细胞耗竭和NK细胞功能障碍。我们进一步讨论外泌体circRNA作为肿瘤-免疫细胞通讯和TME重塑介质的作用,连接代谢应激反应与适应性免疫抑制。值得注意的是,circRNA驱动的免疫代谢环路可能导致对免疫检查点抑制剂和代谢疗法耐药。通过整合代谢、免疫和转化研究视角,本综述指出了关键知识空白,包括circRNA功能的情境依赖性、检测标准化的挑战,以及多组学分层策略的必要性。我们提出,靶向circRNA介导的免疫代谢网络是HCC精准治疗的有前景前沿方向。
Hepatocellular carcinoma (HCC) is distinguished by profound metabolic reprogramming and a highly immunosuppressive tumor microenvironment, two hallmarks that cooperatively drive tumor progression and therapeutic resistance. While metabolic rewiring and immune escape have traditionally been studied as parallel processes, the molecular regulators that integrate these pathways remain incompletely defined. Circular RNAs (circRNAs) are a type of covalently closed non-coding RNAs with exceptionally stable and regulatory versatility, and have recently emerged as critical modulators of both cancer metabolism and immune signaling. However, their coordinated role at the intersection of metabolism and immunology in HCC has not been systematically synthesized. This review provides a comprehensive, mechanistic framework that positions circRNAs as central regulators of immunometabolic crosstalk in HCC. We summarize how circRNAs modulate glycolysis, lipid remodeling, glutamine metabolism, and redox balance while simultaneously regulating immune checkpoint pathways, macrophage polarization, T-cell depletion, and NK-cell dysfunction. We further discuss exosomal circRNAs as mediators of tumor-immune communication and remodeling of the tumor microenvironment, linking metabolic stress responses to adaptive immune suppression. Importantly, we highlight circRNA-driven immunometabolic circuits as contributors to resistance against immune checkpoint inhibitors and metabolic therapies. By integrating metabolic, immune, and translational perspectives, this review identifies key knowledge gaps, including context-dependent circRNA functions, challenges in detection standardization, and the need for multi-omic stratification strategies. We propose that targeting circRNA-mediated immunometabolic networks represents a promising frontier for precision therapy in HCC.
MEMBER ACCOUNT
登录成功会直接打开下一页。